An Updated Review on Repurposing of Metformin DOI Open Access

Hind A Rikabi,

Dalia A. Abdulla,

Mahmoud M. E. Mudawi

и другие.

Asian Journal of Pharmaceutical Research and Health Care, Год журнала: 2024, Номер 16(4), С. 344 - 351

Опубликована: Окт. 1, 2024

A BSTRACT Even with the swift progress in scientific understanding of various diseases such as cancer, cardiovascular diseases, and diabetes, there remains a need for effective new treatments. Now, other drug development strategies, repurposing existing medicines to treat which will save time money, are being investigated. Since metformin is one most used drugs worldwide it investigated uses, therefore, this review potential uses beyond its established use diabetes highlighted several polycystic ovary syndrome (PCOS), weight reduction, lowering plasma lipids, delaying aging process, possible role reducing mortality pandemic COVID-19. An extensive literature search was conducted on PubMed Google Scholar databases identify relevant literature.

Язык: Английский

Beyond Antivirals: Alternative Therapies for Long COVID DOI Creative Commons

Achilleas Livieratos,

Charalambos Gogos,

Karolina Akinosoglou

и другие.

Viruses, Год журнала: 2024, Номер 16(11), С. 1795 - 1795

Опубликована: Ноя. 19, 2024

Long COVID or Post-Acute Sequelae of SARS-CoV-2 infection (PASC) is a condition characterized by numerous lingering symptoms that persist for weeks to months following the viral illness. While treatment PASC still evolving, several therapeutic approaches beyond traditional antiviral therapies are being investigated, such as immune-modulating agents, anti-inflammatory drugs, and various supportive interventions focusing at alleviating enhancing recovery. We aimed summarize breadth available evidence, identify knowledge gaps, highlight promising non-antiviral COVID/PASC. followed framework scoping methodology mapping existing evidence from range studies, including randomized clinical trials, observational research, case series. Treatments evaluated include metformin, low-dose naltrexone (LDN), dexamethasone, statins, omega-3 fatty acids, L-arginine, emerging like intravenous immunoglobulin (IVIg) apheresis. Early findings suggest metformin has strongest particularly large phase 3 while LDN dexamethasone show potential based on studies. However, many treatments lack robust, large-scale trials. This review emphasizes need further research confirm efficacy these guide practice management.

Язык: Английский

Процитировано

0

An Updated Review on Repurposing of Metformin DOI Open Access

Hind A Rikabi,

Dalia A. Abdulla,

Mahmoud M. E. Mudawi

и другие.

Asian Journal of Pharmaceutical Research and Health Care, Год журнала: 2024, Номер 16(4), С. 344 - 351

Опубликована: Окт. 1, 2024

A BSTRACT Even with the swift progress in scientific understanding of various diseases such as cancer, cardiovascular diseases, and diabetes, there remains a need for effective new treatments. Now, other drug development strategies, repurposing existing medicines to treat which will save time money, are being investigated. Since metformin is one most used drugs worldwide it investigated uses, therefore, this review potential uses beyond its established use diabetes highlighted several polycystic ovary syndrome (PCOS), weight reduction, lowering plasma lipids, delaying aging process, possible role reducing mortality pandemic COVID-19. An extensive literature search was conducted on PubMed Google Scholar databases identify relevant literature.

Язык: Английский

Процитировано

0